Filing Details

Accession Number:
0001251769-22-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-01 18:22:44
Reporting Period:
2022-02-25
Accepted Time:
2022-03-01 18:22:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1251769 Apollo Endosurgery Inc. APEN Surgical & Medical Instruments & Apparatus (3841) 161630142
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449439 G. Jeffrey Black 1120 S. Capital Of Texas Highway
Building One, Suite 300
Austin TX 78746
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-25 15,000 $5.48 240,000 No 4 P Direct
Common Stock Acquisiton 2022-02-28 15,000 $5.66 255,000 No 4 P Direct
Common Stock Acquisiton 2022-03-01 10,000 $6.20 265,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents weighted average price of shares purchased. Prices ranged between $5.40 - $5.50, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Represents weighted average price of shares purchased. Prices ranged between $5.58 - $5.76, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  3. Represents weighted average price of shares purchased. Prices ranged between $5.80 - $6.30, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.